Scicon-MR update – 90mg strength

Gliclazide

THERAPEUTIC SEGMENT:
Oral Antidiabetic

INDICATIONS:
Type 2 diabetes mellitus.

BRIEF DESCRIPTION:
Scicon-MR 90mg (Gliclazide) is an oral antidiabetic agent containing a modified-release version of the active ingredient Gliclazide. Scicon-MR 90mg belongs to a class of oral hypoglycemic agents known as sulphonylureas and is used to help control blood glucose levels in patients with Type 2 diabetes.

DOSAGE FORM:

Tablets
30mg
60mg
90mg

Disclaimer: For use under medical prescription only

Categories: ,

Reviews

There are no reviews yet.

Be the first to review “Gliclazide”

Your email address will not be published. Required fields are marked *